Michael Herman Chui

22PUBLICATIONS
71CO-AUTHORS
Haematological tumoursPredictive and prognostic markersSolid tumoursMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 07, 2026
ERBB2 amplification is a late event in the pathogenesis of high-grade endometrial carcinomas with heterogeneous HER2 expression.

Michael Herman Chui, David N Brown, Jorge S Reis-Filho

|Dec 18, 2025
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions.

Tu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen

|Dec 15, 2025
Extensive Foamy Cell Change in Serous Tubal Intraepithelial Carcinoma and Tubal High-grade Serous Carcinoma.

M Herman Chui, Sarah Chiang

|Nov 11, 2025
High-grade Serous Neoplasm of Fallopian Tube Mimicking a Low-grade Lesion.

M Herman Chui

|May 06, 2025
Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation.

M Herman Chui, Eun-Young Kang, Ryan M Kahn

|Dec 04, 2024
Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity.

Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu

Pageof 4

Frequent Collaborators

10 joint publications

Britta Weigelt

3 joint publications

Rachel N Grisham

2 joint publications

Qin Zhou

2 joint publications

Jorge S Reis-Filho